Debbie's Dream Foundation


What are you searching for?

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Board of Directors
Corporate Advisory Council
Honorary Board
Scientific and Medical Advisory Board

Raising Awareness. Funding Research. Supporting Patients. Achieving the DREAM!

Debbie's Dream Foundation: Curing Stomach Cancer (DDF) is dedicated to raising awareness about stomach cancer, advancing funding for research, and providing education and support internationally to patients, families, and caregivers. DDF seeks as its ultimate goal to make the cure for stomach cancer a reality.

Debbie's Dream Foundation's Response to COVID-19

Debbie’s Dream Foundation: Curing Stomach Cancer (DDF) cares about the general well-being of our community. With the unforeseeable spread of the coronavirus (COVID-19), we are doing our part in minimizing the spread of this disease by participating in “social distancing” as outlined in the Centers for Disease Control and Prevention guidelines. As a result, we have decided to cancel some of our upcoming events, and our staff is currently working remotely to comply with the latest recommendations of the CDC and other government and healthcare organizations.


Read more

News & Updates


March 20, 2020 – Care of Individuals with Cancer During COVID-19

ASCO invited its members to submit questions about issues and challenges they see emerging while caring for individuals with cancer…

Read More

Survivor Stories

Denise Leprine-New York

It all began in Oct 2016 when I was going for routine blood work every few months after being diagnosed…

Read More

Keep up with the latest news and events:



Upcoming Events

Debbie’s Dream Foundation: Curing Stomach Cancer is proud to partner with Catholic Hospice, Inc. to bring patients and caregivers monthly support groups, with the option of attendance in-person and via teleconference.

Samuel J. Klempner, MD is a gastrointestinal medical oncologist at the Massachusetts General Hospital Cancer Center and assistant professor at Harvard Medical School in Boston, MA.  His clinical and research focus is gastroesophageal cancers and novel therapies.  He works in a multidisciplinary team to optimize and individualize treatment using molecular characterization across all stages of stomach and esophageal cancers.  Dr. Klempner conducts clinical trials and translational research with new targeted agents and immune therapies. He is active in the stomach cancer community including local outreach, education, and advocacy.